Financial

Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart Failure

KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for patients with heart failure, today announced the company has closed a $39 million Series B financing. The round includes new investor, Australia-based Hostplus, venture debt from Oxford Finance LLC, as well as support from existing […]

V-Wave Closes $70M Financing to Support Pivotal Study of its Heart Failure Therapy

CAESAREA, Israel, April 26, 2018 /PRNewswire/ — V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF), announced today that it has closed a Series C financing of $70 million led by Deerfield Management along with participation from new investors – […]

Edwards Lifesciences Reports First Quarter Results

IRVINE, Calif., April 24, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2018. First Quarter and Recent Highlights: Sales were $895 million, or $938 million on an adjusted basis Global THVT sales […]

Boston Scientific Announces Results For First Quarter 2018

MARLBOROUGH, Mass., April 25, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.379 billion during the first quarter ended March 31, 2018. This represents growth of 10.1 percent on a reported basis, 6.2 percent on an operational1 basis and 5.2 percent on an organic2 basis, all compared to the prior year period. The company reported […]

Medicure to Announce Fiscal Year End 2017 Financial Results on April 30, 2018

WINNIPEG, April 24, 2018 /PRNewswire/ – Medicure Inc. (“Medicure”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the year ended December 31, 2017 after market close on Monday, April 30, 2018.  Medicure will hold a conference call and webcast regarding the results on Tuesday, May 1, 2018at 7:30 AM Central Time (8:30 AM Eastern Time). […]

BD Board Declares Dividends

FRANKLIN LAKES, N.J., April 23, 2018 /PRNewswire/ — The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.75 per common share, payable on June 29, 2018 to holders of record on June 8, 2018.  The indicated annual dividend rate is $3.00 per share.  In addition, the Board of Directors has declared […]

Bardy Diagnostics™ Announces Appointment of Alan Levy to Board of Directors

SEATTLE, April 24, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s only P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced today the appointment of Alan J. Levy, PhD to its Board of […]